Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "DexCom Inc (DXCM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. This analytical report serves as a ...
At the conference, first-ever accuracy and performance data will be presented for Dexcom's upcoming G7 15 Day system, 1 showing an overall mean absolute relative difference (MARD) of 8.0%, making it ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results